BRANDICOURT OLIVIER 4
4 · BeiGene, Ltd. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
BRANDICOURT OLIVIER
Director
Transactions
- Award
Share Option (Right to Buy)
2024-02-29+27,794→ 27,794 totalExercise: $12.74Exp: 2034-02-28→ Ordinary Shares (27,794 underlying)
Footnotes (2)
- [F1]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
- [F2]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.